<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02550769</url>
  </required_header>
  <id_info>
    <org_study_id>NOTES-LRAB_TAU-2015</org_study_id>
    <nct_id>NCT02550769</nct_id>
  </id_info>
  <brief_title>Study of NOTES-TME Versus L-LAR in Rectal Cancer</brief_title>
  <acronym>NOTESvsL-LAR</acronym>
  <official_title>Multicenter Prospective Randomized Controlled Study of the Transanal Total Mesorectal Excision Versus Laparoscopic Low Anterior Resection in Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      INTRODUCTION: Transanal TME (T-TME) combined with laparoscopy, called hybrid-NOTES, is a less
      invasive procedure that responds to some of the limitations of the rectal laparoscopic
      approach.

      MAIN OBJECTIVE: To analyze that the T-TME gets a faster recovery due to a lower conversion
      rate to open surgery than laparoscopic low anterior resection (L-LAR) in rectal cancer with
      the same pathological, functional and oncologic results.

      METHODOLOGY: A prospective multicenter randomized controlled study of patients with rectal
      cancer that, were randomized in the T-TME- and L-LAR group. The main variables are: general
      morbidity, anastomotic dehiscence, conversion rate to open surgery and hospital stay. The
      sample calculation is 58 patients per group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      INTRODUCTION: The laparoscopic total mesorectal excision (TME) has provided better patient
      recovery with less morbidity and shorter hospital stay compared with open surgery. However in
      laparoscopic low rectal surgery, overall conversion to open surgery is around 20%. Transanal
      TME (T-TME) combined with laparoscopy, called hybrid-NOTES, is a less invasive procedure that
      responds to some of the limitations of the rectal laparoscopic approach.

      MAIN OBJECTIVE: To analyze that the T-TME gets a faster recovery due to a lower conversion
      rate to open surgery than laparoscopic low anterior resection (L-LAR) in rectal cancer with
      the same pathological, functional and oncologic results.

      METHODOLOGY: A prospective multicenter randomized controlled study of patients diagnosed with
      adenocarcinoma of the rectum that after inclusion and exclusion criteria, were randomized in
      the T-TME- and L-LAR group. The main variables are: general morbidity, anastomotic
      dehiscence, conversion rate to open surgery and hospital stay. The other variables studied
      were: demographic, surgical, pathological, 30-day morbidity and mortality, quality of life
      and oncologic results. The sample calculation is 53 patients per group. With an estimated
      loss of 10%, the final number will be 116 patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the effectiveness of the T-TME versus L-LAR with the Dindo-Claviens classification in patients with rectal cancer.</measure>
    <time_frame>30 days</time_frame>
    <description>Evaluate surgical complications 30 days after surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate the effectiveness of the T-TME versus L-LAR with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) CR-30 score in patients with rectal cancer.</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate functional results 6 months after ileostomy closure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate the effectiveness of the T-TME versus L-LAR with the EORTC QLQ-CR29 score in patients with rectal cancer.</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate functional results 6 months after ileostomy closure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate the effectiveness of the T-TME versus L-LAR with the LARS score in patients with rectal cancer.</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate functional results 6 months after ileostomy closure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>TRANSANAL TOTAL MESORECTAL EXCISION</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transanal approach of total mesorectal excision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic-LAR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Type of surgical intervention as control group: Laparoscopic low anterior resection with total mesorectal excision for rectal cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TRANSANAL TOTAL MESORECTAL EXCISION</intervention_name>
    <description>The technique begins with the TEO equipment and a purse string 1 cm distal to the tumor. The dissection progresses in the posterior part until the laparoscopic TME field is reached. After the section of the rectum and TME transanal dissection, the anvil of the circular mechanical stapler is introduced through the TEO rectoscope. In the laparoscopic field, the mesosigma is sectioned at the point where the colon section is to be performed. The TEO rectoscope is withdrawn, and the bag containing the specimen is removed through the anus. The stapler is inserted. From the laparoscopic field, the strings of the purse are tightened and the purse is closed around the rectal stump with a clip. Then the stapler are joined to perform the anastomosis and a loop ileostomy is placed in the right flank.</description>
    <arm_group_label>TRANSANAL TOTAL MESORECTAL EXCISION</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic-LAR</intervention_name>
    <description>Standard laparoscopic low anterior resection of the rectum with total mesorectal excision and colorectal anastomosis</description>
    <arm_group_label>Laparoscopic-LAR</arm_group_label>
    <other_name>Laparoscopic Low Anterior Resecion of the rectum</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years

          -  Patients with rectal cancer stage: cT1-2-3, cN0-1, cM0.

          -  Tumor equal or below 10 cm from the anal verge, candidates to (ETM) low anterior
             resection and anastomosis, with or without preoperative chemo-radiotherapy.

          -  Adenocarcinoma of low or moderate differentiation

          -  ASA I, II, III.

        Exclusion Criteria:

          -  Do not sign informed consent

          -  Pregnant patients

          -  Liver cirrhosis

          -  Undifferentiated adenocarcinoma.

          -  cT4

          -  Metastatic disease (M1)

          -  chronic renal failure on dialysis

          -  ASA IV

          -  BMI &lt;18 and&gt; 35 kg / m2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serra-Aracil Xavier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporacio Parc Tauli. Parc Tauli University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serra-Aracil Xavier, MD, PhD</last_name>
    <phone>34-93-723-1010</phone>
    <phone_ext>21490</phone_ext>
    <email>jserraa@tauli.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Serra-Aracil Xavier, MD,PhD</last_name>
    <phone>34-93-723-1010</phone>
    <phone_ext>21490</phone_ext>
    <email>jserraa@tauli.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Parc Tauli University Hospital</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serra-Aracil Xavier, MD</last_name>
      <phone>34-93-723-1010</phone>
      <phone_ext>21490</phone_ext>
      <email>jserraa@tauli.cat</email>
    </contact>
    <contact_backup>
      <last_name>Mora-Lopez Laura, MD</last_name>
      <phone>34-93-723-1010</phone>
      <phone_ext>21490</phone_ext>
      <email>lmora@tauli.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Zarate-Pinedo Alba, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Serra-Aracil X, Mora-LÃ³pez L, Casalots A, Pericay C, Guerrero R, Navarro-Soto S. Hybrid NOTES: TEO for transanal total mesorectal excision: intracorporeal resection and anastomosis. Surg Endosc. 2016 Jan;30(1):346-54. doi: 10.1007/s00464-015-4170-5. Epub 2015 Mar 27.</citation>
    <PMID>25814073</PMID>
  </reference>
  <reference>
    <citation>Serra-Aracil X. [Transanal total mesorectal excision]. Cir Esp. 2014 Apr;92(4):221-2. doi: 10.1016/j.ciresp.2014.01.002. Epub 2014 Feb 24. Spanish.</citation>
    <PMID>24576748</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2015</study_first_submitted>
  <study_first_submitted_qc>September 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>September 14, 2015</last_update_submitted>
  <last_update_submitted_qc>September 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Xavier Serra-Aracil</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Transanal NOTES</keyword>
  <keyword>Transanal TME</keyword>
  <keyword>Laparoscopic Low Anterior Resection</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

